Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Taiwanese (TAIEX) Healthcare Sector Analysis

UpdatedNov 14, 2025
DataAggregated Company Financials
Companies218
  • 7D-2.1%
  • 3M-3.8%
  • 1Y-0.7%
  • YTD7.2%

Over the last 7 days, the Healthcare industry has dropped 2.1%, driven by a pullback from Caliway Biopharmaceuticals of 9.5%. In contrast, EirGenix has gained 22%. As for the longer term, the industry's performance has been flat for the past year. Looking forward, earnings are forecast to grow by 95% annually.

Sector Valuation and Performance

Has the Taiwanese Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 17 Nov 2025NT$1.6tNT$268.7bNT$12.5b21.3x131.9x6.1x
Wed, 15 Oct 2025NT$1.7tNT$266.8bNT$8.4b21.7x207.7x6.5x
Fri, 12 Sep 2025NT$1.8tNT$266.1bNT$8.7b22.8x209x6.8x
Sun, 10 Aug 2025NT$1.7tNT$262.5bNT$13.6b21.5x121.7x6.3x
Tue, 08 Jul 2025NT$1.6tNT$261.0bNT$16.4b20.4x97.4x6.1x
Thu, 05 Jun 2025NT$1.5tNT$260.9bNT$16.3b19.5x94.4x5.9x
Sat, 03 May 2025NT$1.4tNT$255.2bNT$12.4b20x116.6x5.7x
Mon, 31 Mar 2025NT$1.6tNT$254.0bNT$11.6b21.4x135.3x6.2x
Wed, 26 Feb 2025NT$1.7tNT$246.5bNT$8.4b23.8x197.6x6.8x
Fri, 24 Jan 2025NT$1.5tNT$246.2bNT$8.7b22.2x175.5x6.2x
Sun, 22 Dec 2024NT$1.4tNT$245.0bNT$8.6b21.7x167.1x5.9x
Tue, 19 Nov 2024NT$1.5tNT$244.5bNT$8.0b22.6x183.4x6x
Thu, 17 Oct 2024NT$1.5tNT$236.4bNT$6.8b24.7x225x6.4x
Sat, 14 Sep 2024NT$1.6tNT$236.4bNT$6.8b24.9x232.1x6.6x
Mon, 12 Aug 2024NT$1.6tNT$230.0bNT$3.9b26.4x399.5x6.8x
Wed, 10 Jul 2024NT$1.7tNT$228.8bNT$3.6b28.7x461x7.2x
Fri, 07 Jun 2024NT$1.5tNT$228.6bNT$3.9b27.3x389.3x6.7x
Sun, 05 May 2024NT$1.4tNT$229.4bNT$4.5b25.5x321.9x6.3x
Tue, 02 Apr 2024NT$1.5tNT$228.8bNT$6.4b26.3x231.2x6.5x
Thu, 29 Feb 2024NT$1.5tNT$226.6bNT$6.7b25.8x219.3x6.5x
Sat, 27 Jan 2024NT$1.4tNT$225.0bNT$5.9b24.8x233x6.2x
Mon, 25 Dec 2023NT$1.4tNT$224.7bNT$5.9b25.5x239x6.2x
Wed, 22 Nov 2023NT$1.4tNT$224.7bNT$6.5b24.9x213.3x6.2x
Fri, 20 Oct 2023NT$1.3tNT$225.3bNT$8.3b24.4x160x5.9x
Sun, 17 Sep 2023NT$1.4tNT$225.2bNT$8.2b26.1x170.6x6.2x
Tue, 15 Aug 2023NT$1.3tNT$221.9bNT$7.0b24.6x187.8x6x
Thu, 13 Jul 2023NT$1.4tNT$226.5bNT$11.5b25.2x121.3x6.2x
Sat, 10 Jun 2023NT$1.4tNT$225.0bNT$11.1b24.9x130x6.4x
Mon, 08 May 2023NT$1.5tNT$220.1bNT$12.0b25.2x123.6x6.8x
Wed, 05 Apr 2023NT$1.4tNT$221.6bNT$13.1b22.1x108.8x6.4x
Fri, 03 Mar 2023NT$1.5tNT$215.2bNT$14.4b21.5x100.9x6.7x
Sun, 29 Jan 2023NT$1.3tNT$214.5bNT$13.8b20.1x94.3x6.1x
Tue, 27 Dec 2022NT$1.3tNT$214.5bNT$13.8b20.9x95.6x6.2x
Thu, 24 Nov 2022NT$1.3tNT$214.4bNT$14.1b17.5x92.5x6.1x
Price to Earnings Ratio

92.5x


Total Market Cap: NT$1.3tTotal Earnings: NT$14.1bTotal Revenue: NT$214.4bTotal Market Cap vs Earnings and Revenue0%0%0%
Taiwanese Healthcare Sector Price to Earnings3Y Average 187x202320242025
Current Industry PE
  • Investors are pessimistic on the Taiwanese Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 132x which is lower than its 3-year average PE of 187x.
  • The industry is trading close to its 3-year average PS ratio of 6.4x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have declined 3.6% per year over the last three years.
  • Meanwhile revenues for these companies have grown 7.8% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Taiwanese Healthcare sector?

TW Market-0.99%
Healthcare-2.08%
Life Sciences13.93%
Healthcare Services2.84%
Healthtech-0.32%
Biotech-1.85%
Medical Equipment-2.53%
Pharma-3.37%
Industry PE
  • Investors are most optimistic about the Healthtech industry which is trading above its 3-year average PE ratio of 12.0x.
    • Analysts are expecting annual earnings decline of 6.4%, which is less than its past year's earnings decline of 28.5%.
Forecasted Growth
  • Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 141% over the next 5 years.
  • This is better than its past earnings growth rate of 4.9% per year.
  • In contrast, the Healthtech industry is expected to see its earnings decline by 6.4% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
6589 EirGenixNT$81.9021.9%
+NT$4.4b		-7.7%PS26.5x
1795 Lotus PharmaceuticalNT$294.005.4%
+NT$3.9b		5.9%PE16.3x
4123 Center LaboratoriesNT$37.658.8%
+NT$2.3b		-20.2%PE15.8x
3218 Universal Vision BiotechnologyNT$157.5016.2%
+NT$1.9b		-25.5%PE13.5x
4142 AdimmuneNT$21.5516.8%
+NT$1.3b		-1.1%PS7.6x

Latest News

4142
NT$21.55
Adimmune
7D
16.8%
1Y
-1.1%
6576
NT$85.20
Foresee Pharmaceuticals
7D
10.6%
1Y
12.4%
6589
NT$81.90
EirGenix
7D
21.9%
1Y
-7.7%
3218
NT$157.50
Universal Vision Biotechnology
7D
16.2%
1Y
-25.5%
1795
NT$294.00
Lotus Pharmaceutical
7D
5.4%
1Y
5.9%
6550
NT$30.10
Polaris Group
7D
-6.1%
1Y
-41.3%
4123
NT$37.65
Center Laboratories
7D
8.8%
1Y
-20.2%
1720
NT$60.60
Standard Chemical & Pharmaceutical
7D
6.7%
1Y
-4.3%
4743
NT$62.50
Oneness Biotech
7D
2.5%
1Y
-41.9%
6785
NT$252.50
Alar Pharmaceuticals
7D
-10.1%
1Y
68.3%
6919
NT$124.00
Caliway Biopharmaceuticals
7D
-9.5%
1Y
141.7%
6446
NT$480.50
PharmaEssentia
7D
-4.1%
1Y
-9.8%
6535
NT$189.00
Lumosa Therapeutics
7D
-6.0%
1Y
-44.2%
6472
NT$568.00
Bora Pharmaceuticals
7D
-8.7%
1Y
-11.5%
6696
NT$276.50
Lin BioScience
7D
-5.6%
1Y
77.8%
7799
NT$617.00
Heron Neutron Medical
7D
-2.8%
1Y
n/a